CEO Mark Tarr Files Intent to Sell $16.7 Million in Company Stock
EHC sits 23% above its 52-week low of $92.53.
Summary
Encompass Health Corp's CEO, Mark Tarr, has filed a Form 144 indicating an intent to sell 150,000 shares of common stock, valued at approximately $16.7 million.
Key Events · Ownership and Investor Activity · EHC
-
CEO Files Intent to Sell Shares
Mark Tarr, CEO of Encompass Health Corp, filed a Form 144 indicating an intent to sell 150,000 shares of common stock.
-
Significant Value of Proposed Sale
The proposed sale has an approximate market value of $16.7 million.
-
Shares Acquired via RSA Vesting
The shares intended for sale were acquired through RSA (Restricted Stock Award) vesting.
Analysis · EHC · Industrial Applications And Services
This Form 144 filing indicates a significant intent to sell by CEO Mark Tarr, representing a notable disposition of shares. While the shares were acquired through RSA vesting, the decision by a top executive to sell a substantial amount of stock can be interpreted negatively by the market, potentially raising questions about executive confidence or personal liquidity needs. This filing follows the company's announcement of strong Q4 and full-year 2025 financial results on February 5th, which may have provided a favorable window for such a sale.
At the time of this filing, EHC was trading at $113.43 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $11.4B. The 52-week trading range was $92.53 to $127.99. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.